N

NeoPhore Ltd

14 employees

NeoPhore is a provider of novel small molecule therapies intended to treat cancer through stimulation of the immune system.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Small Molecule Therapeutics
Simulation
Therapeutics
Translation Service
Oncology
Genetics
Translational Medicine
Drug Discovery
Immuno-oncology
Cancer

Date founded

2017

Funding rounds raised

Total raised

$21M

from 11 investors over 11 rounds

N

NeoPhore Ltd raised $7.4M on January 19, 2023

Investors: Astellas Venture Capital L.L.C., SIXTH ELEMENT CAPITAL LLP, 3B Future Health Fund and Claris Ventures SGR SpA

N

NeoPhore Ltd raised $21M on March 9, 2021

Investors: Astellas Venture Capital L.L.C., SIXTH ELEMENT CAPITAL LLP, 3B Future Health Fund, 2invest financial and Claris Ventures SGR SpA

N

NeoPhore Ltd raised undisclosed on April 27, 2018

Investors: Innovate UK

N

NeoPhore Ltd raised $4M on November 16, 2017

Investors: SIXTH ELEMENT CAPITAL LLP

FAQ